Merck CEO Rob Davis has business development on the brain as he builds 'pipeline of the future'
Does Merck have everything it needs for a successful pipeline? In short, no, CEO Rob Davis told investors and analysts during the company’s Q3 call on Thursday. But he’s got his eye on “a list of potential places to play” when it comes to M&A.
The chief executive took a moment during the Q&A session to highlight Merck’s business development plans, which may or may not include Seagen after talks of a buyout reportedly stalled back in August over price. Davis kept short on the details, vaguely admitting that “our urgency on business development has not changed.”
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.